Corcept Therapeutics (CORT) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.93% |
| Dec 31, 2025 | 19.76% |
| Sep 30, 2025 | 21.33% |
| Jun 30, 2025 | 17.51% |
| Mar 31, 2025 | 22.49% |
| Dec 31, 2024 | 17.16% |
| Sep 30, 2024 | 17.23% |
| Jun 30, 2024 | 14.47% |
| Mar 31, 2024 | 14.62% |
| Dec 31, 2023 | 15.83% |
| Sep 30, 2023 | 14.61% |
| Jun 30, 2023 | 14.53% |
| Mar 31, 2023 | 17.60% |
| Dec 31, 2022 | 22.38% |
| Sep 30, 2022 | 23.84% |
| Jun 30, 2022 | 27.04% |
| Mar 31, 2022 | 31.85% |
| Dec 31, 2021 | 40.75% |
| Sep 30, 2021 | 43.01% |
| Jun 30, 2021 | 46.22% |
| Mar 31, 2021 | 44.33% |
| Dec 31, 2020 | 41.37% |
| Sep 30, 2020 | 41.35% |
| Jun 30, 2020 | 40.19% |
| Mar 31, 2020 | 41.23% |
| Dec 31, 2019 | 40.56% |
| Sep 30, 2019 | 43.14% |
| Jun 30, 2019 | 44.55% |
| Mar 31, 2019 | 37.19% |
| Dec 31, 2018 | 36.69% |
| Sep 30, 2018 | 37.83% |
| Jun 30, 2018 | 36.60% |
| Mar 31, 2018 | 30.48% |
| Dec 31, 2017 | 29.65% |
| Sep 30, 2017 | 29.55% |
| Jun 30, 2017 | 29.44% |
| Mar 31, 2017 | 2.49% |
| Dec 31, 2016 | 13.65% |
| Sep 30, 2016 | 13.93% |
| Jun 30, 2016 | 13.76% |
| Mar 31, 2016 | 22.70% |
| Dec 31, 2015 | 20.61% |
| Sep 30, 2015 | 23.12% |
| Jun 30, 2015 | 25.58% |